Campbell & CO Investment Adviser LLC Purchases Shares of 82,433 Haleon PLC Sponsored ADR $HLN

Campbell & CO Investment Adviser LLC acquired a new position in Haleon PLC Sponsored ADR (NYSE:HLN) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 82,433 shares of the company’s stock, valued at approximately $855,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nuveen LLC bought a new position in Haleon during the 1st quarter worth approximately $58,870,000. Millennium Management LLC lifted its position in Haleon by 697.2% in the first quarter. Millennium Management LLC now owns 4,216,504 shares of the company’s stock valued at $43,388,000 after purchasing an additional 3,687,613 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Haleon by 22.0% during the first quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company’s stock valued at $192,428,000 after purchasing an additional 3,372,155 shares during the period. Sculptor Capital LP grew its holdings in shares of Haleon by 22.1% in the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company’s stock worth $111,645,000 after purchasing an additional 1,962,770 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in shares of Haleon by 933.1% in the first quarter. Jane Street Group LLC now owns 2,155,716 shares of the company’s stock worth $22,182,000 after buying an additional 1,947,050 shares during the period. Institutional investors own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

HLN has been the subject of a number of recent analyst reports. The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Haleon currently has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Stock Up 0.1%

Shares of Haleon stock opened at $9.89 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42. The company has a market cap of $44.02 billion, a P/E ratio of 25.35, a PEG ratio of 2.98 and a beta of 0.20. The company’s fifty day simple moving average is $9.28 and its two-hundred day simple moving average is $9.92.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.